Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.38), $0.06 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $14.6 million versus the consensus estimate of $14.6 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

Earnings